Beaton Management Co. Inc. purchased a new position in shares of Colgate-Palmolive (NYSE:CL) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 6,100 shares of the company’s stock, valued at approximately $452,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. Transamerica Financial Advisors Inc. lifted its holdings in shares of Colgate-Palmolive by 0.3% during the 1st quarter. Transamerica Financial Advisors Inc. now owns 25,183 shares of the company’s stock valued at $1,844,000 after buying an additional 67 shares during the period. Ronald Blue & Co. LLC lifted its holdings in shares of Colgate-Palmolive by 1.1% during the 1st quarter. Ronald Blue & Co. LLC now owns 3,501 shares of the company’s stock valued at $256,000 after buying an additional 37 shares during the period. USS Investment Management Ltd lifted its holdings in shares of Colgate-Palmolive by 1.6% during the 1st quarter. USS Investment Management Ltd now owns 683,600 shares of the company’s stock valued at $50,036,000 after buying an additional 10,600 shares during the period. Stifel Financial Corp increased its stake in shares of Colgate-Palmolive by 0.8% in the 1st quarter. Stifel Financial Corp now owns 303,934 shares of the company’s stock worth $22,250,000 after purchasing an additional 2,360 shares in the last quarter. Finally, ARS Investment Partners LLC increased its stake in shares of Colgate-Palmolive by 0.5% in the 1st quarter. ARS Investment Partners LLC now owns 35,531 shares of the company’s stock worth $2,601,000 after purchasing an additional 175 shares in the last quarter. 72.83% of the stock is owned by institutional investors.
In other Colgate-Palmolive news, insider Jennifer Daniels sold 7,375 shares of the business’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total value of $539,702.50. Following the transaction, the insider now directly owns 38,691 shares in the company, valued at approximately $2,831,407.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the transaction, the director now owns 36,268 shares in the company, valued at $2,557,619.36. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 181,048 shares of company stock valued at $13,168,995. 1.02% of the stock is owned by corporate insiders.
Shares of Colgate-Palmolive (NYSE CL) traded down $0.31 during trading on Tuesday, hitting $75.14. 4,352,470 shares of the company’s stock were exchanged, compared to its average volume of 3,128,750. The firm has a market capitalization of $66,253.04, a P/E ratio of 29.01, a P/E/G ratio of 3.45 and a beta of 0.80. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. Colgate-Palmolive has a 1-year low of $63.43 and a 1-year high of $77.27.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter in the prior year, the company earned $0.73 EPS. Colgate-Palmolive’s revenue was up 2.8% compared to the same quarter last year. sell-side analysts expect that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.
CL has been the subject of a number of analyst reports. Macquarie initiated coverage on Colgate-Palmolive in a research note on Thursday, September 14th. They issued a “neutral” rating and a $76.00 price target for the company. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Wednesday, September 20th. Morgan Stanley upgraded Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $75.00 to $84.00 in a research report on Monday, September 25th. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a report on Thursday, September 28th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a report on Sunday, October 8th. Three equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $76.33.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.